Differentiating human leukemia cells express heparanase that degrades heparan sulfate in subendothelial extracellular matrix
- PMID: 2973542
- DOI: 10.1016/0145-2126(88)90003-3
Differentiating human leukemia cells express heparanase that degrades heparan sulfate in subendothelial extracellular matrix
Abstract
Human promyelocytic (HL-60) and monoblast-like (U-937) leukemia cell lines were tested for expression of an endoglycosidase (heparanase) capable of degrading heparan sulfate (HS) side chains in the subendothelial extracellular matrix (ECM). Heparanase activity has been previously shown to be expressed by activated lymphocytes and macrophages and by highly metastatic tumor cells, in correlation with their ability to invade blood vessels and extracellular matrices. Incubation of HL-60 and U-937 cells with sulfate-labeled ECM in the presence of 12-O-tetradecanoyl-phorbol-13-acetate (TPA) resulted in heparanase-mediated release of heparan sulfate degradation products. This degradation was inhibited by heparin, stimulated by plasminogen and not expressed by cells treated with retinoic acid or dimethylsulfoxide and undergoing neutrophilic differentiation. Heparanase activity was not detected in media conditioned by HL-60 and U-937 cells but was found in their cell lysates, regardless of whether or not the cells were exposed to TPA. These findings imply that TPA-induced differentiation of human myeloid leukemic cells to macrophage-like cells, but not to neutrophilic granulocytes, is associated with expression on the cell surface of a preformed heparanase activity. The enzyme may serve as a marker for human cell differentiation into macrophages, allowing the differentiating cells to traverse the vascular compartment and reach their target sites.
Similar articles
-
Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.J Cell Physiol. 1986 Aug;128(2):299-306. doi: 10.1002/jcp.1041280223. J Cell Physiol. 1986. PMID: 2426287
-
Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.Int J Cancer. 1985 Apr 15;35(4):483-91. doi: 10.1002/ijc.2910350411. Int J Cancer. 1985. PMID: 3157649
-
Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix.Blood. 1990 Jun 1;75(11):2204-12. Blood. 1990. PMID: 1693299
-
Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.Invasion Metastasis. 1992;12(2):112-27. Invasion Metastasis. 1992. PMID: 1399400 Review.
-
Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix.Semin Thromb Hemost. 1987 Oct;13(4):475-88. doi: 10.1055/s-2007-1003524. Semin Thromb Hemost. 1987. PMID: 3321438 Review.
Cited by
-
The role of heparanase in pulmonary cell recruitment in response to an allergic but not non-allergic stimulus.PLoS One. 2015 Jun 3;10(6):e0127032. doi: 10.1371/journal.pone.0127032. eCollection 2015. PLoS One. 2015. PMID: 26039697 Free PMC article.
-
Translocation of heparanase into nucleus results in cell differentiation.Cancer Sci. 2007 Apr;98(4):535-40. doi: 10.1111/j.1349-7006.2007.00420.x. Epub 2007 Jan 31. Cancer Sci. 2007. PMID: 17284253 Free PMC article.
-
Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology.J Antibiot (Tokyo). 2017 Nov 1. doi: 10.1038/ja.2017.138. Online ahead of print. J Antibiot (Tokyo). 2017. PMID: 29089599 Review.
-
Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.FEBS J. 2017 Jan;284(1):42-55. doi: 10.1111/febs.13932. Epub 2016 Nov 16. FEBS J. 2017. PMID: 27758044 Free PMC article. Review.
-
Basic fibroblastic growth factor as a potential meningeal angiogenic factor.Skull Base Surg. 1993;3(3):117-22. doi: 10.1055/s-2008-1060573. Skull Base Surg. 1993. PMID: 17170900 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources